
|Articles|August 18, 2008
FDA clears Iridex IQ Laser Systems
Mountain view, Calif. - Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
Advertisement
Mountain view, Calif.
- Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
The clearance is for specific applications in dermatology as well as ophthalmology and ENT/otolaryngology. It covers the Iridex IQ 532 (green laser), IQ 577 (yellow), IQ 630-670 (red) and IQ 810 (infrared) laser products.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
3
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
4
FDA Feedback Supports BLA Pathway for Sonelokimab in HS
5


















